GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » LTR Pharma Ltd (ASX:LTP) » Definitions » Machinery, Furniture, Equipment

LTR Pharma (ASX:LTP) Machinery, Furniture, Equipment : A$0.00 Mil (As of Jun. 2023)


View and export this data going back to 2023. Start your Free Trial

What is LTR Pharma Machinery, Furniture, Equipment?

LTR Pharma's Machinery, Furniture, Equipment for the quarter that ended in Jun. 2023 was A$0.00 Mil.

LTR Pharma Machinery, Furniture, Equipment Historical Data

The historical data trend for LTR Pharma's Machinery, Furniture, Equipment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LTR Pharma Machinery, Furniture, Equipment Chart

LTR Pharma Annual Data
Trend Jun21 Jun22 Jun23
Machinery, Furniture, Equipment
- - -

LTR Pharma Semi-Annual Data
Jun21 Jun22 Jun23
Machinery, Furniture, Equipment - - -

LTR Pharma Machinery, Furniture, Equipment Calculation

Machinery, Furniture, Equipment represents those fixed assets specifically dealing with tools, equipment and office furniture.

LTR Pharma (ASX:LTP) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » LTR Pharma Ltd (ASX:LTP) » Definitions » Machinery, Furniture, Equipment
Comparable Companies
Traded in Other Exchanges
N/A
Address
9A/204 Alice Street, Brisbane, QLD, AUS, 4000
Website
https://www.ltrpharma.com
LTR Pharma Ltd is a clinical stage pharmaceutical company focused on holistically improving men's health, physically and mentally, through the commercialization of an intranasal spray treatment for Erectile Dysfunction. SPONTAN is a Vardenafil-based nasal delivery formulation designed to be a lower dose fast-acting administration that provides a rapid and high availability to a patient's bloodstream compared with the incumbent oral ED treatment products on market.

LTR Pharma (ASX:LTP) Headlines

No Headlines